Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $484,912 - $631,616
5,887 Added 1805.83%
6,213 $513,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $11,764 - $17,444
136 Added 71.58%
326 $31,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $1.22 Million - $1.53 Million
-11,955 Reduced 98.44%
190 $22,000
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $1.44 Million - $1.77 Million
-13,561 Reduced 52.75%
12,145 $1.57 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $706,938 - $883,336
8,432 Added 48.81%
25,706 $2.66 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $481,364 - $554,719
-6,118 Reduced 26.15%
17,274 $1.45 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $1.48 Million - $1.88 Million
20,631 Added 747.23%
23,392 $2.13 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $185,511 - $241,421
2,761 New
2,761 $220,000
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $1,323 - $1,769
-23 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $1,205 - $1,863
23 New
23 $4,000
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $35,348 - $40,470
-493 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $325,045 - $398,345
-5,281 Reduced 91.46%
493 $108,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $321,842 - $371,903
5,774 New
5,774 $1.07 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $10,727 - $14,347
-224 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $10,395 - $12,754
224 New
224 $34,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $21,347 - $27,236
-574 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $6,589 - $7,681
195 Added 51.45%
574 $65,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $13,753 - $14,716
379
379 $41,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.